Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Genetic Tech Spn ADR (GENE)

Genetic Tech Spn ADR (GENE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Gene achieves key milestones and growth Globe Newswire - Thu Jul 28, 2022

MELBOURNE, Australia, July 28, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in...

GTG.AX : 0.039 (+2.63%)
GENE : 0.7650 (-1.92%)
Completion of AffinityDNA Acquisition expanding global direct-to-consumer business Globe Newswire - Thu Jul 14, 2022

MELBOURNE, Australia, July 14, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in...

GTG.AX : 0.039 (+2.63%)
GENE : 0.7650 (-1.92%)
GeneType Risk Assessment Test onboarding in 16 clinics Globe Newswire - Fri Jul 1, 2022

MELBOURNE, Australia, July 01, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in...

GTG.AX : 0.039 (+2.63%)
GENE : 0.7650 (-1.92%)
Acquisition of global direct to consumer ecommerce business Globe Newswire - Mon May 16, 2022

MELBOURNE, Australia, May 16, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in...

GTG.AX : 0.039 (+2.63%)
GENE : 0.7650 (-1.92%)
Genetic Technologies drives leadership in precision medicine with Multi-Risk Test Globe Newswire - Fri Apr 8, 2022

MELBOURNE, Australia, April 08, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (NASDAQ: GENE, ASX: GTG) (“GENE” or the “Company”), a global leader...

GTG.AX : 0.039 (+2.63%)
GENE : 0.7650 (-1.92%)
Genetic Technologies Reports Q2 FY22 Cash Flow Results Globe Newswire - Wed Jan 19, 2022

Q2 momentum sets the stage for a strong FY22...

GTG.AX : 0.039 (+2.63%)
GENE : 0.7650 (-1.92%)
GENE Presents Study Involving 200,000 Participants at 2021 San Antonio Breast Cancer Symposium Globe Newswire - Fri Dec 10, 2021

MELBOURNE, Australia, Dec. 10, 2021 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in...

GTG.AX : 0.039 (+2.63%)
GENE : 0.7650 (-1.92%)
Genetic Technologies Announces New Partnership and geneType COVID-19 Risk Test Patent Allowance from the USPTO Globe Newswire - Thu Dec 9, 2021

MELBOURNE, Australia, Dec. 09, 2021 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in...

GTG.AX : 0.039 (+2.63%)
GENE : 0.7650 (-1.92%)
Genetic Technologies Reports Q1 FY22 Results Globe Newswire - Mon Oct 25, 2021

Genetype MultiTest submitted for regulatory approval as commercialization plans gather momentum increase in cash receipts over prior quarter ...

GTG.AX : 0.039 (+2.63%)
GENE : 0.7650 (-1.92%)
Genetic Technologies Limited Interview to Air on Bloomberg TV (U.S.) on the RedChip Money Report® Globe NewsWire - Thu Sep 30, 2021

MELBOURNE, Australia, Sept. 30, 2021 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in Genomics based tests in health, wellness...

GTG.AX : 0.039 (+2.63%)
GENE : 0.7650 (-1.92%)

Barchart Exclusives

How to Profitably Exploit a Temporary Sentiment Reversal in Planet Labs (PL) Barchart - Sat Dec 14, 9:15AM CST
While PL stock has been one of the surprise winners this year, a corrective lull isn’t out of the question. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot